Publications | smondal

Citations

Patents:

1. P. R. Thompson, S. Mondal, "INHIBITORS OF PROTEIN ARGININE DEIMINASE 1 AND METHODS OF PREPARATION AND USE THEREOF" International Patent, WO2021/003078 A1.

2. K. Fitzgerald, H. Fiachra, L. Galia, P. R. Thompson, S. Mondal, ‘TARGETING OF STING FOR THE TREATMENT OF INFLAMMATORY DISEASES’ US Patent, Application Serial No. 63/147,387.

3. P. R. Thompson, S. Mondal, ‘PHOTOCAGED CITRULLINE ANALOGS AND METHODS FOR SITE-SPECIFIC INCORPORATION OF CITRULLINE INTO PROTEINS’ US Patent, Application Serial No. 63/161,918.

Publications:

34. Priyanka,# B. Raymandal,# S. Mondal* 'Native State Stabilization of Amyloidogenic Proteins by Kinetic Stabilizers: Inhibition of Protein Aggregation and Clinical Relevance' ChemMedChem, 2024, 19, e202400244. (Impact factor: 3.6) #Co-first Author

33. F. Humphries, L. Shmuel-Galia, Z. Jiang, J. Y. Zhou, L. Barasa, S. Mondal, R. Wilson, N. Sultana, S. A. Shaffer, S.-L. Ng, G. S. Pesiridis, P. R. Thompson, K. A. Fitzgerald, 'Targeting STING oligomerization with small-molecule inhibitors' Proc. Natl. Acad. Sci. 2023, 120, e2305420120. (Impact factor: 9.4)

32. D. Giri, S. Mondal, G. Mugesh, 'Chemical Biology of Thyroid Hormones' AsiaChem, 2023, 3, 136.

31. S. Mondal, Y. Chen, G. J. Lockbaum, S. Sen, S. Chaudhuri, A. C. Reyes, J. M. Lee, A. N. Kaur, N. Sultana, M. D. Cameron, S. A. Shaffer, C. A. Schiffer, K. A. Fitzgerald, P. R. Thompson, 'Dual Inhibitors of Main Protease (MPro) and Cathepsin L as Potent Antivirals against SARS-CoV2' J. Am. Chem. Soc. 2022, 144, 21035. (Impact factor: 14.5)

30. S. Mondal, S. Wang, Y. Zheng, S. Sen, A. Chatterjee, P. R. Thompson, ‘Site-specific Incorporation of Citrulline into Proteins in mammalian cells’ Nat. Commun. 2021, 12, 45. (Impact factor: 14.7)

Behind the Paper, written by S. Mondal and P. R. Thompson.

29. S. Mondal, P. R. Thompson, ‘Chemical Biology of Protein Citrullination by Protein Arginine Deiminases (PADs)’ Curr. Opin. Chem. Biol. 2021, 63, 19. (Impact factor: 6.9)

28. F. J. Li, R. Surolia, H. Li, Z. Wang, G. Liu, T. Kulkarni, A. V.F. Massicano, J. A. Mobley, S. Mondal, J. A. de Andrade, S. A. Coonrod, P. R. Thompson, K. Wille, S. E. Lapi, M. Athar, V. J. Thannickal, A. B. Carter, V. B. Antony, ‘Citrullinated-vimentin mediates development and progression of lung fibrosis’ Sci. Transl. Med. 2021, 13, eaba2927. (Impact factor: 15.8)

27. G. Griffante, F. Gugliesi, S. Pasquero, V. Dell’Oste, M. Biolatti, A. J. Salinger, S. Mondal, P. R. Thompson, E. Weerapana, R. J. Lebbink, J. A. Soppe, T. Stamminger, V. Girault, A. Pichlmair, G. Oroszlán, D. M. Coen, M. De Andrea, S. Landolfo, ‘Human cytomegalovirus-induced host protein citrullination is crucial for viral replication’ Nat. Commun. 2021, 12, 3910. (Impact factor: 14.7)

26. M. T. M. Monreal, L. Massarenti, A. S. Rebak, S. Mondal, L. Šenolt, N. Ødum, M. L. Nielsen, P. R. Thompson, C. H. Nielsen, D. Damgaard, ‘Applicability of small-molecule inhibitors in the study of peptidyl arginine deiminase 2 (PAD2) and PAD4’ Front. Immunol. 2021, 12, 716250. (Impact factor: 5.7)

25. O. Ashur-Fabian, D. Moskovich, Y. Finkelshtein, A. Alfandari, A. Rosemarin, T. Lifschytz, A. Weisz, S. Mondal, H. Ungati, A. Katzav, D. Kidron, G. Mugesh, M. Ellis, B. Lerer, ‘Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: A new paradigm in ovarian cancer treatment’ Oncogene 2021, 40, 6248-6257. (Impact factor: 6.9)

24. F. M. C. Sodré, S. Bissenova, Y. Bruggeman, R. Tilvawala, D. P. Cook, C. Berthault, S. Mondal, A. Callebaut, S. You, R. Scharfmann, R. Mallone, P. R. Thompson, C. Mathieu, M. Buitinga, L. Overbergh, ‘Peptidylarginine Deiminase Inhibition Prevents Diabetes Development in NOD Mice’ Diabetes 2021, 70, 516. (Impact factor: 7.7)

23. Y. Tian, S. Qu, H. B. Alam, A. M. Williams, Z. Wu, Q. Deng, B. Pan, J. Zhou, B. Liu, X. Duan, J. Ma, S. Mondal, P. R. Thompson, K. A. Stringer, T. J. Standiford, Y. Li, ‘Peptidylarginine deiminase 2 has potential as both a biomarker and therapeutic target of sepsis’ JCI Insight 2020, 5, e138873. (Impact factor: 6.3)

22. H. S. Loring, S. S. Parelkar, S. Mondal, P. R. Thompson* "Identification of the first noncompetitive SARM1 inhibitors" Bioorg. Med. Chem. 2020, 28, 115644. (Impact factor: 3.3)

21. S. Mondal, D. Manna, K. Raja, G. Mugesh* "Halogen Bonding in Biomimetic Deiodination of Thyroid Hormones, their Metabolites and Halogenated Nucleosides" ChemBioChem 2020, 21, 911. (Impact factor: 2.6)

[This article has been selected as Very Important Paper by the editors of the Journal]

[This article has been highlighted in the Cover Page of the journal]

20. Z. Wu, Q. Deng, B. Pan, H. B. Alam, Y. Tian, U. F. Bhatti, B. Liu, S. Mondal, P. R. Thompson, Y. Li* "Inhibition of PAD2 Improves Survival in a Mouse Model of Lethal LPS-Induced Endotoxic Shock" Inflammation 2020, 43, 1436. (Impact factor: 4.5)

19. S. Mondal, D. Giri, G. Mugesh* "Halogen Bonding in the Molecular Recognition of Thyroid Hormones and Their Metabolites by Transport Proteins and Thyroid Hormone Receptors" J. IISc 2020, 100, 231. (Impact factor: 1.8)

18. F. Li, L. Miao, T. Xue, H. Qin, S. Mondal, P. R. Thompson, S. A. Coonrod, X. Liu, X. Zhang* "Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells" J. Exp. Clin. Cancer Res. 2019, 38, 414. (Impact factor: 11.4)

17. S. Mondal, X. Gong, X. Zhang, A. J. Salinger, L. Zheng, S. Sen, E. Weerapana, X. Zhang, P. R. Thompson* "Halogen Bonding Increases the Potency and Isozyme selectivity of Protein Arginine Deiminase 1 (PAD1) Inhibitors" Angew. Chem. Int. Ed. 2019, 58, 12476. (Impact factor: 16.1)

16. S. Mondal and P. R. Thompson* "Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination" Acc. Chem. Res. 2019, 52, 818. (Impact factor: 16.7)

15. S. Mondal and G. Mugesh* "Dehalogenation of Halogenated Nucleobases and Nucleosides by Organoselenium Compounds" Chem. Eur. J. 2019, 25, 1773. (Impact factor: 3.9)

14. S. Sen, S. Mondal, L. Zheng, A. J. Salinger, W. Fast, E. Weerapana and P. R. Thompson* "Development of a Suicide Inhibition-Based Protein Labeling Strategy for Nicotinamide N-Methyltransferase" ACS Chem. Biol. 2019, 14, 613. (Impact factor: 3.5)

13. N. Mishra, L. Schwerdtner, K. Sams, S. Mondal, F. Ahmad, R. E. Schmidt, S. A. Coonrod, P. R. Thompson, M. M. Lerch and L. Bossaller* "Cutting Edge: Protein Arginine Deiminase 2 and 4 Regulate NLRP3 Inflammasome–Dependent IL-1β Maturation and ASC Speck Formation in Macrophages" J. Immunol. 2019, 203, 795. (Impact factor: 5.4)

12. Y. Liu, Y. L. Lightfoot, N. Seto, C. Carmona-Rivera, E. Moore, R Goel, L. O’Neil, P. Mistry, V. Hoffmann, S. Mondal, P. N. Premnath, K. Gribbons, S. Dell’Orso, K. Jiang, P. R. Thompson, H.-W. Sun, S. A. Coonrod, and M. J. Kaplan* "Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7–dependent lupus" JCI Insight 2018, 3, e124729. (Impact factor: 6.3)

11. S. Mondal, S. S. Parelkar, M. Nagar, and P. R. Thompson* "Photochemical Control of Protein Arginine Deiminase (PAD) Activity" ACS Chem. Biol. 2018, 13, 1057. (Impact factor: 3.5)

[This article has been highlighted in the Front Cover Page of the journal]

10. V. V. Nemmara, V. Subramanian, A. Muth, S. Mondal, A. J. Salinger, A. J. Maurais, R. Tilvawala, E. Weerapana, and P. R. Thompson * "The Development of Benzimidazole-Based Clickable Probes for the Efficient Labeling of Cellular Protein Arginine Deiminases (PADs)" ACS Chem. Biol. 2018, 13, 712. (Impact factor: 3.5)